Advances in Clinical Chemistry 61

Main
Medicine
Advances in Clinical Chemistry 61

Advances in Clinical Chemistry 61

Gregory S. Makowski (Eds.)

0 / 0

Πόσο σας άρεσε αυτό το βιβλίο;

Ποια είναι η ποιότητα του ληφθέντος αρχείου;

Κατεβάστε το βιβλίο για να αξιολογήσετε την ποιότητά του

Ποια είναι η ποιότητα των ληφθέντων αρχείων;

Κατηγορίες:

Έτος:

2013

Εκδότης:

Academic Press, Elsevier

Γλώσσα:

english

Σελίδες:

1

ISBN 10:

0124076807

ISBN 13:

9780124076808

Σειρές:

Advances in Clinical Chemistry 61

Αρχείο:

PDF, 3.95 MB

IPFS:

,

english, 2013

Διαβάστε online

Η μετατροπή σε βρίσκεται σε εξέλιξη

Η μετατροπή σε απέτυχε

Ίσως σας ενδιαφέρει

Gregory S. Makowski (Eds.) — Advances in Clinical Chemistry 60

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Unknown — Non Alcoholic Fatty Liver Disease A Practical Guide

Jesse E. Adams, Fred S. Apple, Allan S. Jaffe — Markers in Cardiology: A Case-Oriented Approach (American Heart Association Monograph Series)

James de Lemos — Biomarkers in Heart Disease (American Heart Association Clinical Series)

Metin Basaranoglu, Brent Aneuschwander — Pathophysiology of Nonalcoholic Steatohepatitis

Roger Williams and Simon D. Taylor-Robinson — Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease

Tran Thi Khanh Tuong, Dang Khoa Tran, Pham Quang Thien Phu — Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan

Yetirajam Rajesh, Devanand Sarkar — Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma

Gregory S. Makowski (Eds.) — Advances in Clinical Chemistry 41

Gregory S. Makowski (Eds.) — Advances in Clinical Chemistry

Gregory S. Makowski (Eds.) — Advances in Clinical Chemistry 55

Jeffrey Laurence — Translating MicroRNAs to the Clinic

Gregory S. Makowski (Eds.) — Advances in Clinical Chemistry Volume 79

Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day — Non-Alcoholic Fatty Liver Disease: A Practical Guide

Naim Alkhouri (editor), Stephen A. Harrison (editor) — Need-to-Know NAFLD: The Complete Guide to Nonalcoholic Fatty Liver Disease (by Team-IRA)

Devanand Sarkar — Non-Alcoholic Steatohepatitis

Roger Williams, Simon D. Taylor-Robinson — Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease (Clinical Dilemmas

Geoffrey C. Farrell, Jacob George — Fatty liver disease: NASH and related disorders

Dimitris Tousoulis — Biomarkers in Cardiovascular Diseases

Oren Tirosh — Liver Metabolism and Fatty Liver Disease

Alan H. B. Wu — Cardiac Markers

David A. Morrow — Cardiovascular Biomarkers: Pathophysiology and Disease Management (Contemporary Cardiology)

Ami Schattner — Metabolic Aspects of Chronic Liver Disease

Masato Yoneda; Yuichi Nozaki; Koji Fujita; Atsushi Nakajima — Insulin Resistance and Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH)

Mao Kang Voung; Jiang Shi Sung — Liver Disease and Peritonitis: Causes, Treatment and Prevention : Causes, Treatment and Prevention

Tatjana Ábel; Gabriella Lengyel — Nonalcoholic Fatty Liver Disease (NAFLD)

Ming-Chao Tsai, Yu-Yin Liu, Chih-Che Lin, Chih-Chi Wang — Gut Microbiota Dysbiosis in Patients with Biopsy- Proven Nonalcoholic Fatty Liver Disease: A Cross- Sectional Study in Taiwan

Φράσεις κλειδιά